• 1752 Citations
  • 19 h-Index
20002020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Hiroyuki Yasuda is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 1752 Citations
  • 19 h-Index
  • 65 Article
  • 1 Comment/debate
  • 1 Editorial
  • 1 Review article

Adoptive transfer of zoledronate-expanded autologous V 39Vδ 2 T-cells in patients with treatment-refractory non-small-cell lung cancer: A multicenter, open-label, single-arm, phase 2 study

Kakimi, K., Matsushita, H., Masuzawa, K., Karasaki, T., Kobayashi, Y., Nagaoka, K., Hosoi, A., Ikemura, S., Kitano, K., Kawada, I., Manabe, T., Takehara, T., Ebisudani, T., Nagayama, K., Nakamura, Y., Suzuki, R., Yasuda, H., Sato, M., Soejima, K. & Nakajima, J., 2020 Sep 18, In : Journal for ImmunoTherapy of Cancer. 8, 2, e001185.

Research output: Contribution to journalArticle

Open Access
  • IGF2 Autocrine-mediated IGF1R activation is a clinically relevant mechanism of osimertinib resistance in Lung Cancer

    Manabe, T., Yasuda, H., Terai, H., Kagiwa, H. D. A., Hamamoto, J., Ebisudani, T., Kobayashi, K., Masuzawa, K., Ikemura, S., Kawa, I. D. A., Hayashi, Y., Fukui, K., Horimoto, K., Fukunaga, K. & Soeji, K. M. A., 2020 Apr 1, In : Molecular Cancer Research. 18, 4, p. 549-559 11 p.

    Research output: Contribution to journalArticle

    Open Access
  • 3 Citations (Scopus)

    Intracellular levels of reactive oxygen species correlate with ABT-263 sensitivity in non-small-cell lung cancer cells

    Ohgino, K., Terai, H., Yasuda, H., Nukaga, S., Hamamoto, J., Tani, T., Kuroda, A., Arai, D., Ishioka, K., Masuzawa, K., Ikemura, S., Kawada, I., Naoki, K., Fukunaga, K. & Soejima, K., 2020 Oct 1, In : Cancer science. 111, 10, p. 3793-3801 9 p.

    Research output: Contribution to journalArticle

    Open Access
  • Targeting Co-Occurring Genomic Alterations in MET Exon 14 Skipping Mutation-Positive NSCLC

    Yasuda, H., 2020 May, In : Journal of Thoracic Oncology. 15, 5, p. 679-680 2 p.

    Research output: Contribution to journalEditorial

    A phase II trial of induction of erlotinib followed by cytotoxic chemotherapy for EGFR mutation-positive non-squamous non-small cell lung cancer patients

    Tani, T., Naoki, K., Yasuda, H., Arai, D., Ishioka, K., Ohgino, K., Yoda, S., Nakayama, S., Satomi, R., Terai, H., Ikemura, S., Sato, T. & Soejima, K., 2019 Nov 1, In : Cancer Chemotherapy and Pharmacology. 84, 5, p. 1065-1071 7 p.

    Research output: Contribution to journalArticle

  • 2 Citations (Scopus)